ClinicalTrials.govpublic full text
Subsequent Bevacizumab Treatment in Patients With HHT. Follow up BABH
hemorrhagic hereditary telangiectasia, hht, vegf therapy, bevacizumab, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 845582
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.